Mechanism of action: Sulpiride ballicule
What it isSelective D2 and D3 antagonist; schizophrenia and, at low dose, depression outside the US.
Why this oneLow doses preferentially block presynaptic autoreceptors, which is the basis for the antidepressant use.
What limits itMarked hyperprolactinemia. Renally cleared; not US-approved.
Molecular structure: Sulpiride
FDA-approved for
Off-label
- schizophrenia
- depression at low dose (approved in Europe and Japan)
⚠ BOXED WARNING
- Increased mortality in elderly patients with dementia-related psychosis
Classes and tags
Clinical profile
Therapeutic safety burden2 / 4
Overdose danger3 / 4
Weight-gain liability1 / 4
Sedation liability2 / 4
QT / Torsades3 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4
Defining liabilityHyperprolactinemia, extrapyramidal effects and torsades risk
Open Sulpiride in the interactive console ↗